Announcements Trials
Browse Landscape

Phase

Phase 2 7Phase 3 2Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 74Colonic Neoplasms 31Rectal Neoplasms 29Neoplasm Metastasis 16Stomach Neoplasms 12Pancreatic Neoplasms 12Esophageal Squamous Cell Carcinoma 8Small Cell Lung Carcinoma 7Neoplasms 6Esophageal Neoplasms 6Rhabdomyosarcoma 4Intestinal Neoplasms 4Gastrointestinal Neoplasms 4Digestive System Neoplasms 4Uterine Cervical Neoplasms 3Sarcoma 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Cholangiocarcinoma 3Biliary Tract Neoplasms 3Rectal Diseases 2Neuroblastoma 2Neoplasms by Histologic Type 2Intestinal Diseases 2Hepatoblastoma 2Gastrointestinal Diseases 2Ganglioneuroblastoma 2Digestive System Diseases 2Colorectal Cancer Metastatic 2Colorectal Adenocarcinoma 2Colonic Diseases 2

Interventions

aflibercept 3Irinotecan 2Bevacizumab 2XELOX 1Vemurafenib 1Panitumumab 1Leucovorin 1IFL protocol 1Fluorouracil 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Colorectal Cancer Metastatic × Irinotecan × Clear all
NCT01670721 2016-11-28

AFEQT

Sanofi

Phase 3 Completed
175 enrolled 6 charts
Gastrointestinal

Colorectal Cancer Metastatic

NCT01249638 2011-03-14

Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC

Ludwig-Maximilians - University of Munich

Phase 3 Unknown
516 enrolled
Gastrointestinal

Colorectal Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡